114 related articles for article (PubMed ID: 21744874)
21. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients.
RodrÃguez-Ferrero ML; Anaya F
Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421
[TBL] [Abstract][Full Text] [Related]
22. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
Fedele F
Clin Ter; 2003; 154(4):231-6. PubMed ID: 14618939
[TBL] [Abstract][Full Text] [Related]
23. [Morpho-functional study of the kidney in patients with kidney disease and liver disease with magnetic resonance].
Shariat Razavi I; Stacul F; Cova M; Artero M; Carraro M; Malalan F; Pozzi Mucelli R; Dalla Palma L
Radiol Med; 1998; 95(1-2):72-81. PubMed ID: 9636731
[TBL] [Abstract][Full Text] [Related]
24. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
[TBL] [Abstract][Full Text] [Related]
25. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
[TBL] [Abstract][Full Text] [Related]
27. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
Catapano AL; Davidson MH; Ballantyne CM; Brady WE; Gazzara RA; Tomassini JE; Tershakovec AM
Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
Denke MA; Grundy SM
Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
[TBL] [Abstract][Full Text] [Related]
29. [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].
Zangos S; Hammerstingl R; Mack MG; Straub R; Engelmann K; Eichler K; Balzer T; Vogl TJ
Rofo; 2001 Nov; 173(11):1034-40. PubMed ID: 11704914
[TBL] [Abstract][Full Text] [Related]
30. [An inhibitor of intestinal cholesterol transporter].
Sano M
Nihon Rinsho; 2013 Sep; 71(9):1661-6. PubMed ID: 24205731
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
[TBL] [Abstract][Full Text] [Related]
32. Effects of probucol on renal function and urinary protein excretion in spontaneously hypercholesterolemic rats fed a normal or high cholesterol diet.
Nakao A; Nosaka K; Imaki H; Noiri E; Toda A; Doi K; Suzuki Y; Fujita T; Kimura S
Kidney Blood Press Res; 2004; 27(2):96-104. PubMed ID: 14764942
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
34. Ezetimibe and recent clinical trials: a look on the bright side.
Ahmed MH
Expert Opin Drug Saf; 2010 Jul; 9(4):511-4. PubMed ID: 20377476
[TBL] [Abstract][Full Text] [Related]
35. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
[TBL] [Abstract][Full Text] [Related]
36. [A comparison between an ionic paramagnetic contrast agent (Gd-DTPA) and a nonionic one (Gd-DTPA-BMA) in functional kidney evaluation with magnetic resonance].
Shariat Razavi I; Piovesana F; Stacul F; Cova M; Artero M; Carraro M; Pozzi Mucelli R; Dalla Palma L
Radiol Med; 1997 Sep; 94(3):208-13. PubMed ID: 9446127
[TBL] [Abstract][Full Text] [Related]
37. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.
Hyodo F; Matsumoto K; Matsumoto A; Mitchell JB; Krishna MC
Cancer Res; 2006 Oct; 66(20):9921-8. PubMed ID: 17047054
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia.
Samaha FF; McKenney J; Bloedon LT; Sasiela WJ; Rader DJ
Nat Clin Pract Cardiovasc Med; 2008 Aug; 5(8):497-505. PubMed ID: 18506154
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
40. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
